US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 15, 2021 (5 years ago)

Phentermine HCL 37.5mg 100 C4

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

What was recalled

PHENTERMINE HCL 37.5MG 100 C4; NDC/UPC 10702002901; RX; CAPSULES

Recalling firm
Cardinal Health Inc.
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0502-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Phentermine recalls

See all
Class II · Moderate risk Terminated

Phentermine HCL 30mg 100 C4

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0501-2021
Class II · Moderate risk Terminated

Phentermine

Reason cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.

Calvin Scott & Company, Inc. NDC 00527-0597-10 D-0011-2021
Class II · Moderate risk Terminated

Phentermine HCL Blue Speckled tablets

Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Calvin Scott & Company, Inc. NDC 10702-0025-10 D-1532-2020
Class II · Moderate risk Terminated

Phentermine HCL White/Blue Speckled tablets

Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Calvin Scott & Company, Inc. NDC 00527-1445-10 D-1531-2020